ABOUT

The high cost of medications is a major challenge for patients and healthcare systems around the world. The emerging field of interventional pharmacoeconomics (see recent paper in JAMA Oncology) identifies opportunities for lower doses, shorter treatment durations, increased treatment intervals, and use of alternative agents. The aim is to use pharmacological and clinical knowledge to lower costs while maintaining equivalent health outcomes. This conference will bring together leaders in this field of research from the fields of pharmacology, health policy and economics, clinical medicine, clinical trials and health care management.